Lista de obras - Raymond P Goodrich - Dominio Público Uruguay

<scp>SARS‐CoV</scp>‐2 seroprevalence among blood donors in Uganda: 2019–2022

artículo científico publicado en 2023

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

artículo científico publicado en 2009

A novel cancer immunotherapy utilizing autologous tumour tissue

artículo científico publicado en 2020

A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia

artículo científico publicado en 2012

An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage

artículo científico publicado en 2005

Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients

artículo científico publicado en 2016

Chemical and biological mechanisms of pathogen reduction technologies

artículo científico publicado en 2014

Comparison of computerized formulae for determination of platelet recovery and survival

artículo científico publicado en 2005

Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects

artículo científico publicado en 2006

Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.

artículo científico publicado en 2014

Development of a riboflavin and ultraviolet light‐based device to treat whole blood ⬇️

artículo científico publicado el 1 de enero de 2013

Dramatic improvements in viral inactivation with brominated psoralens, naphthalenes and anthracenes

artículo científico publicado en 1993

Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial

artículo científico publicado en 2016

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

artículo científico publicado en 2005

Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates.

artículo científico publicado en 2017

Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies

artículo científico publicado en 2023

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood ⬇️

artículo científico publicado el 9 de agosto de 2011

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis.

artículo científico publicado en 2009

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

artículo científico publicado en 2005

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

artículo científico publicado en 2008

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety ⬇️

artículo científico publicado el 10 de marzo de 2011

Functional inactivation of white blood cells by Mirasol treatment.

artículo científico publicado en 2006

Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions.

artículo científico publicado en 2010

Hemostatic efficacy of pathogen-inactivated- versus untreated- platelets: a randomized controlled trial.

artículo científico publicado en 2018

Ignorance is not bliss.

artículo científico publicado en 2018

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice

artículo científico publicado en 2013

Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function

artículo científico publicado en 2010

Improving blood safety and patient outcomes with pathogen reduction technology

artículo científico publicado en 2011

Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.

artículo científico publicado en 2017

In reply to: "Is the SCID mouse model applicable to human acute lung injury?".

artículo científico publicado en 2012

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology

artículo científico publicado en 2010

In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days

artículo científico publicado en 2011

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.

artículo científico publicado en 2011

Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light

artículo científico publicado en 2013

Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates

artículo científico publicado en 2009

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.

artículo científico publicado en 2015

Measurement of transmitted light as an indicator of cryopreserved platelet viability

artículo científico publicado en 1996

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

artículo científico publicado en 2006

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

artículo científico publicado en 2011

Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light

artículo científico publicado en 2020

Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.

artículo científico publicado en 2006

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

artículo científico publicado en 2007

Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light

artículo científico publicado en 2020

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

artículo científico publicado en 2004

Pathogen reduction of whole blood: utility and feasibility.

artículo científico publicado en 2017

Photochemical and photophysical studies of 3-amino-6-iodoacridine and the inactivation of lambda phage

artículo científico publicado en 1996

Photochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin.

artículo científico publicado en 2017

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system

artículo científico publicado en 2012

Pilot Acute Safety Evaluation of Innocell™ Cancer Immunotherapy in Canine Subjects

artículo científico publicado en 2020

Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.

artículo científico publicado en 2013

Preparation of cryoprecipitate from riboflavin and UV light-treated plasma ⬇️

artículo científico publicado el 17 de febrero de 2012

Preservation of metabolic activity in lyophilized human erythrocytes ⬇️

artículo científico publicado el 1 de febrero de 1992

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time ⬇️

artículo científico publicado el 1 de enero de 2013

Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.

artículo científico publicado en 2011

Protein translation occurs in platelet concentrates despite riboflavin/UV light pathogen inactivation treatment.

artículo científico publicado en 2016

Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.

artículo científico publicado en 2011

Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage

artículo científico publicado en 2017

Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood. ⬇️

artículo científico publicado en 2016

Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets

artículo científico publicado en 2016

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

artículo científico publicado en 2014

Reduction of prion infectivity in packed red blood cells.

artículo científico publicado en 2008

Refrigerated storage of lyophilized and rehydrated, lyophilized human red cells.

artículo científico publicado en 1993

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

artículo científico publicado en 2004

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

artículo científico publicado en 2012

Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment

artículo científico publicado en 2013

Riboflavin and ultraviolet light: impact on dengue virus infectivity.

artículo científico publicado en 2016

Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells

artículo científico publicado en 2015

Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives.

artículo científico publicado en 1994

Survival of lyophilized and reconstituted human red blood cells in vivo

artículo científico publicado en 1995

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

artículo científico publicado en 2006

The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.

artículo científico publicado en 2010

The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.

artículo científico publicado en 2011

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses

artículo científico publicado en 2014

The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection

artículo científico publicado en 2012

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

artículo científico publicado en 2008

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.

artículo científico publicado en 2015

Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage

artículo científico publicado en 2015

Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.

artículo científico publicado en 2016

Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?

artículo científico publicado en 2012

Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

artículo científico publicado en 2009

Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.

artículo científico publicado en 2014

Lista de obras de Raymond P Goodrich

<scp>SARS‐CoV</scp>‐2 seroprevalence among blood donors in Uganda: 2019–2022

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

A novel cancer immunotherapy utilizing autologous tumour tissue

A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia

An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage

Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients

Chemical and biological mechanisms of pathogen reduction technologies

Comparison of computerized formulae for determination of platelet recovery and survival

Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects

Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.

Development of a riboflavin and ultraviolet light‐based device to treat whole blood ⬇️

Dramatic improvements in viral inactivation with brominated psoralens, naphthalenes and anthracenes

Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates.

Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood ⬇️

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis.

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety ⬇️

Functional inactivation of white blood cells by Mirasol treatment.

Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions.

Hemostatic efficacy of pathogen-inactivated- versus untreated- platelets: a randomized controlled trial.

Ignorance is not bliss.

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice

Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function

Improving blood safety and patient outcomes with pathogen reduction technology

Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.

In reply to: "Is the SCID mouse model applicable to human acute lung injury?".

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology

In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.

Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light

Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.

Measurement of transmitted light as an indicator of cryopreserved platelet viability

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light

Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

Pathogen reduction of whole blood: utility and feasibility.

Photochemical and photophysical studies of 3-amino-6-iodoacridine and the inactivation of lambda phage

Photochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin.

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system

Pilot Acute Safety Evaluation of Innocell™ Cancer Immunotherapy in Canine Subjects

Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.

Preparation of cryoprecipitate from riboflavin and UV light-treated plasma ⬇️

Preservation of metabolic activity in lyophilized human erythrocytes ⬇️

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time ⬇️

Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.

Protein translation occurs in platelet concentrates despite riboflavin/UV light pathogen inactivation treatment.

Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.

Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage

Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood. ⬇️

Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

Reduction of prion infectivity in packed red blood cells.

Refrigerated storage of lyophilized and rehydrated, lyophilized human red cells.

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment

Riboflavin and ultraviolet light: impact on dengue virus infectivity.

Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells

Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives.

Survival of lyophilized and reconstituted human red blood cells in vivo

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.

The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses

The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.

Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage

Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.

Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?